While further studies are needed to confirm the relevance of these results, it is intriguing to speculate that this specific metabolic signature might be explored as a companion biomarkers for TIMP3-based treatment of diabetic nephropathy. The gene discussed is TIMP3; the disease is diabetic kidney disease.